We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Adverse events after SARS‐CoV‐2 vaccination in solid organ transplant recipients: A systematic review.
- Authors
Villavicencio, Aasith; Ebisu, Yosuke; Raja, Mohammed; Sanchez‐Covarrubias, Alex P.; Reynolds, John M.; Natori, Yoichiro
- Abstract
Abbreviations DSA donor-specific antibodies SARS-CoV-2 Severe acute respiratory virus syndrome 2 SOT solid organ transplant To the Editor, The immunogenicity in solid organ transplant (SOT) recipients against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination is suboptimal.[1] However, adverse events including rejection post-vaccination have not been reviewed, which are also of great interest for clinicians taking care of transplant recipients. For three cohort studies, of 1721 recipients, three recipients developed rejection.[[3]] Acute cell-mediated rejection was seen at 8- and 11-days post-vaccination in the kidney[2] and liver transplant recipient,[5] respectively. In conclusion, even though SARS-CoV-2 vaccine immunogenicity is suboptimal in SOT recipients, given the safety profile, we recommend providing vaccination to SOT recipients in addition to other preventive strategies.
- Subjects
TRANSPLANTATION of organs, tissues, etc.; SARS-CoV-2; VACCINATION; TENSION headache; BK virus
- Publication
Transplant Infectious Disease, 2022, Vol 24, Issue 6, p1
- ISSN
1398-2273
- Publication type
Article
- DOI
10.1111/tid.13936